Chitosans have been proposed as alternative, biocompatible cationic polymers for nonviral gene delivery. However, the low transfection efficiency and low specificity of chitosan need to be addressed before clinical application. We prepared galactosylated chitosan-graft-polyethylenimine (GC-g-PEI) copolymer by an imine reaction between periodate-oxidized GC and low-molecular-weight PEI. The molecular weight and composition were characterized using gel permeation chromatography column with multi-angle laser scattering and 1 H nuclear magnetic resonance, respectively. The copolymer was complexed with plasmid DNA in various copolymer/DNA (N/P) charge ratios, and the complexes were characterized. GC-g-PEI showed good DNA-binding ability and superior protection of DNA from nuclease attack and had low cytotoxicity compared to PEI 25K. GC-g-PEI/DNA complexes showed higher transfection efficiency than PEI 25K in both HepG2 and HeLa cell lines. Transfection efficiency into HepG2, which has asialoglycoprotein receptors, was higher than that into HeLa, which does not. GCg-PEI/DNA complexes also transfected liver cells in vivo after intraperitoneal (i.p.) administration more effectively than PEI 25K. These results suggest that GC-g-PEI can be used in gene therapy to improve transfection efficiency and hepatocyte specificity in vitro and in vivo.
Introduction
Gene therapy has gained significant interest due to its ability to treat human disease by correcting genetic deficiencies of key metabolic enzymes. Although gene therapy holds great promise, progress in developing effective clinical protocols has been quite slow. The problem lies in the development of safe and efficient gene delivery systems. 1, 2 While most gene therapy protocols in present clinical trials employ recombinant viral vectors, safety concerns have led to the pursuit of nonviral alternatives. Viral vectors are most commonly constructed from adenovirus, retrovirus, adeno-associated virus, herpes simplex virus and lentivirus. They are all highly efficient under specific circumstances, but the potential risks of undesired immune and toxic side reactions have raised concerns. 3, 4 Nonviral vectors can be classified into lipoplex-and polyplex-forming carriers, 5 and they have several advantages over viral vectors, including safety, lower immunogenicity and the ability to transfer larger DNA molecules. 6 Therefore, the development of nonviral vectors is a very important undertaking.
Chitosans have been proposed as alternative, biocompatible cationic polymers that are suitable for nonviral gene delivery. 7 However, this system is significantly limited by its low transfection efficiency and low cell specificity. 8, 9 To address this, several ligands, such as transferrin-, 10, 11 folate-, 9,12 mannose- 13 and galactose 2, 14, 15 -conjugated chitosan, have been designed for receptormediated endocytosis gene delivery. Of the ligandconjugated chitosans, galactosylated chitosans (GCs) have been reported as hepatocyte-targeting gene carriers due to the specific ligand-receptor interactions between galactose moieties and asialoglycoprotein receptors (ASGPR). ASGPR are present at a high density only on hepatocytes and are retained in several human hepatoma cell lines. [16] [17] [18] These receptors can not only bind galactose-bearing ligands, but also internalize them within membrane-bound vesicles or endosomes. 19 GC was expected to have significant potential as a safe, hepatocyte-targeting gene carrier; however, the transfection efficiency of GC was not high enough for further clinical application. 15, 20, 21 Among nonviral vectors, polyethylenimine (PEI) has been shown to condense plasmids into colloidal particles that can effectively transfect a variety of cells, both in vitro and in vivo, due to its buffering capacity. 22 PEI exists as a branched polymer, as well as in linear form.
The branched form of PEI shows a theoretical ratio of primary to secondary to tertiary amine groups of 1:2:1. These amines have pKa values spanning the physiological pH range, resulting in excellent buffering capacity. 23 On the other hand, many studies have addressed concerns about the toxicity of conventional PEI. The cytotoxicity of PEI is dependent on its molecular weight; lower molecular weight PEI has a lower cytotoxicity. 24, 25 In a previous study, we prepared chitosan-graft-PEI (CHI-g-PEI) as a gene carrier. 26 The CHI-g-PEI showed low cell toxicity and high transfection efficiency. However, this system also had limited cell specificity. Therefore, in this study, we prepared GC-graft-low molecular weight PEI (GC-g-PEI) to obtain better hepatocyte specificity. The physicochemical properties of the GC-g-PEI/DNA complexes were analyzed, and their cytotoxicity and hepatocyte specificity were also characterized. Transfection efficiency was investigated both in vitro and in vivo.
Results and discussion
An important step in the advancement of gene therapy is the development of an efficient, targeted gene delivery system. Receptor-mediated gene transfer is a promising gene delivery technique. GC was expected to be a safe hepatocyte-targeting gene carrier, but its transfection efficiency was too low for further clinical application. 15, 20, 21 In a previous study, we prepared CHI-g-PEI as a gene carrier. 26 CHI-g-PEI showed good cell viability and high transfection efficiency but poor cell specificity. Therefore, to obtain both gene transfer ability and hepatocyte specificity, and to reduce toxicity compared to PEI alone, we prepared GC-g-PEI using GC and low molecular weight PEI.
Synthesis and characterization of copolymer
We succeeded in synthesizing GC-g-PEI copolymer by an imine reaction between periodate-oxidized GC and an amine group of PEI (Figure 1 ). The composition of the synthesized copolymer was analyzed by 1 H nuclear magnetic resonance ( 1 H NMR; Figure 2 ). The chemical composition of the galactose groups in GC was determined to be 15.36 mol% by assigning the protons of the methoxy group of chitosan and the protons of the 1-carbon in galactose, respectively. After oxidation, the proton peak of the 2-carbon of GC was decreased (shown by the dotted line) due to cleavage of the carbon-carbon bond by the periodate ion, leading to the formation of a dialdehyde. The degree of oxidized GC determined from integral values of the 2-carbon proton peak was 35.78 mol% ( Table 1 ). The assignment of chemical shifts of PEI was determined by a previously reported method. 27 As shown in Figure 2 , the proton peaks of PEI (ÀNHCH 2 CH 2 À) appeared at 3.3-2.5 p.p.m., indicating that PEI was grafted to the GC chain. The characteristics of the synthesized copolymer are shown in Table 1 . After oxidation, the proton peak of the 2-carbon of chitosan was decreased (the part shown within the dotted line) and the molecular weight of periodate-oxidized GC was decreased due to cleavage of the carbon-carbon bond, leading to the formation of a dialdehyde and the depolymerization of the polymer by the periodate ion. 26, 28 The molecular weight of GC-g-PEI (25.73 kDa) was very close to that of PEI 25K, which was used as a control. Figure 1 Proposed reaction scheme for synthesis of galactosylated chitosan-graft-polyethylenimine (GC-g-PEI).
GC-g-PEI for hepatocyte targeting H-L Jiang et al
Characterization of GC-g-PEI/DNA complexes One prerequisite of a polymeric gene carrier is DNA condensation. The condensation capability of GC-g-PEI with DNA was evaluated using agarose gel electrophoresis. Figure 3a demonstrates that the migration of DNA was completely retarded when the N/P ratio of GC-g-PEI/DNA complexes was about 3. The formation of GC-g-PEI/DNA complexes was also monitored by observing changes in morphology, particle sizes and x potentials as a function of N/P ratio. Figure  3b shows a representative morphology of GC-g-PEI/ DNA complexes, which had a well-formed spherical shape and compact structure.
Particle size is a particularly important factor that influences the access and passage of complexes through the targeted site. As shown in Figure 3c , all complexes were less than 85 nm, and particle sizes tended to decrease with an increase in the N/P ratio. It is thought that the hydrophilic groups of the galactose residue prevent the aggregation of complexes. Also, since the polymer complexes with DNA through ionic interactions, at high N/P ratios, there are net electrostatic repulsive forces to prevent aggregation. The relatively homogenous size distributions of complexes, measured by dynamic light scattering, were unimodal ( Figure 3d ).
Upon self-assembly of DNA and cationic polymer, the highly negative charge of the DNA is rapidly neutralized until the surface charge of the complexes becomes positive at higher N/P ratios. A positive surface charge is necessary for binding to anionic cell surfaces, which facilitates uptake by the cell. 25, 30 Figure 3c shows the x potentials of GC-g-PEI/DNA complexes at various N/P ratios. At an N/P ratio of 0.1, where complexes could not form completely, the x potential of the copolymer/DNA complexes was negative. With increasing N/P ratios, x potential rapidly increased to positive values. Abbreviations: GC-g-PEI, galactosylated chitosan-graft-polyethylenimine; MW, molecular weight.
For effective gene expression, the DNA in the gene vehicle should be protected from enzyme degradation. 27 In contrast to control (naked) plasmid DNA (pDNA), DNA in the complexes was protected from DNase I (Figure 3e ). This result suggests that more intact DNA could transfer to cells.
Cytotoxicity of GC-g-PEI
To investigate the cytotoxicity of the GC-g-PEI copolymer, cell viability was determined at various concentrations of copolymer using the CellTiter 96 AQ ueous One Solution Cell Proliferation Assay. It should be noted that free polymer, rather than DNA complexes, was used to measure the cytotoxicity. This was done to simulate a worst-case scenario and obtain better sensitivity, since, in general, toxicity is reduced by the formation of DNA polyplexes. 25 Figure 4 shows that the GC-g-PEI copolymer has low cytotoxicity compared to both PEI 25K and low molecular weight PEI (PEI 1800Da) in three different cell lines. GC-g-PEI copolymer exhibited good cell viability, whereas the cell viability of PEI 25K was drastically decreased with increasing concentration. The cytotoxicity of cationic polymers is probably caused by polymer aggregation on cell surfaces, impairing important membrane functions. Also, cationic polymers may interfere with critical intracellular processes: in particular, the primary amine was reported to disrupt protein kinase C function through disturbance of protein kinase activity. 31, 32 Hong et al. 33 also reported that PEI induced more Lactate Dehydrogenase (LDH) leakage as compared to the other polycationic polymers such as poly-Llysine and dendrimer (G5-NH 2 ) in KB and Rat2 cell lines, because the PEI possesses a much greater charge/ monomer ratio. On the other hand, chitosan has been reported to have a low toxicity, 34 although a few investigators have observed a dose-dependent toxicity of chitosan at high doses in vitro. 35, 36 In a previous study, we found significantly higher cell viability of chitosan compared to PEI 25K in three different cell lines (293T, HeLa and HepG2). 26 The cell viability of chitosan decreased slightly with increasing doses, and the cell viability of chitosan was maintained at more than 80% of the nontreated control group even at a high concentration (100 mg/ml). In addition, the cell viability was further increased after the galactosylation of chitosan. The cell viability of GC-g-PEI (70% of control) was higher than that of CHI-g-PEI (50% of control) at a concentration of 100 mg/ml. It was reported that although cationic polymers with high charge density showed high cell lytic and toxic properties, a reduction of charge density caused less cell toxicity. [36] [37] [38] We found more lower x potentials of GC-g-PEI/DNA complexes (+22.9974.16 mV, N/P ¼ 14) than PEI 25K/DNA complexes (+38.5773.71 mV, N/P ¼ 7). Therefore, it is reasonable to assume that GC-g-PEI showed lower toxicity than either PEI 25K or low molecular weight PEI 1800Da, due to the properties of biocompatible GC-g-PEI for hepatocyte targeting H-L Jiang et al chitosan and the shielding of the primary amines of PEI 1800Da after reaction with periodate-oxidized GC.
In vitro transfection: luciferase activity assay HepG2 cells are well-known model cells for parenchymal cells in the liver, which have good cell-surface expression of ASGPR. To determine the optimal N/P ratio of GC-g-PEI/DNA complexes for transfection, HepG2 cells were transfected with complexes prepared at different N/P ratios ( Figure 5a ). The transfection efficiency of the copolymer increased with increasing N/P ratio, whereas the transfection efficiency of PEI 25K alone decreased due to cytotoxicity. The maximal transfection efficiency of GC-g-PEI/DNA was observed at an N/P ratio of 14 and tended to decrease with further increases in the N/P ratio. Gao et al. 2 obtained similar results using galactosylated low molecular weight chitosan (gal-LMWC), and they attributed decreased transfection efficiency to free gal-LMWC binding competitively with cell surface receptors, reducing the binding of gal-LMWC/DNA complexes and inhibiting endocytosis. Also, interestingly, GC-g-PEI/DNA complexes had transfection efficiencies similar to Lipofectamine. Figure 5b shows the transfection efficiencies of GC/DNA, CHI-g-PEI/DNA, GC-g-PEI/DNA and PEI/DNA complexes at functional N/P ratios. We found that the transfection efficiency of GC-g-PEI/DNA complexes was higher than those of GC/DNA, CHI-g-PEI/DNA and PEI/DNA complexes. The transfection efficiency of GC-g-PEI/DNA complexes in HepG2 and HeLa cells was also compared to demonstrate the effect of galactose on receptor-mediated gene transfer 2, 14, 15 (Figure 5c ). The luciferase activity of GC-g-PEI/DNA complexes was normalized to that of CHI-g-PEI/DNA complexes in both HepG2 and HeLa cells. GC-g-PEI/DNA complexes showed higher transfection efficiency compared to CHI-g-PEI/DNA complexes in HepG2 cells, but not in HeLa cells, which have no ASGPR on the cell surface, indicating that the galactose ligand on GC-g-PEI played a significant role in ASGPR recognition and enhanced transfection efficiency in HepG2 cells. The transfection efficiency of GCg-PEI/DNA complexes was greatly reduced in the presence of an excess of free galactose (100 mM), indicating that GC-g-PEI/DNA complexes are absorbed via receptor-mediated endocytosis (Figure 5d ).
To further elucidate the mechanism of transfection, we checked the buffering capacity of GC-g-PEI copolymer. HeLa cells were treated during transfection with These results strongly demonstrate that GC-g-PEI has enhanced gene transfer efficiency and specificity in vitro.
In our previous study, galactosylated chitosan-graftpoly (ethylene glycol) (GCP) was developed as a DNA carrier.
14 GCP/DNA complexes showed low cytotoxicity, however, the transfection efficiency was found very low. Recently, galactosylated PEIs (gal-PEI) as alternative gene carriers have been introduced owing to PEImediated high transfection efficiency by endosomal escape of polyplexes cargo to cytosol. 22, 39 Zenta et al.
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synthesized gal-PEI as a gene carrier. They demonstrated that neutral gal-PEI/DNA complexes showed high transfection efficiency and hepatocyte specificity. However, in our previous study, we found that gal-PEI also showed high cytotoxicity similar to PEI 25K at high concentration due to the cytotoxicity of PEI. 41 To overcome cytotoxicity and nonspecificity, galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) (GPP) was prepared as a gene carrier. 41 GPP showed good cell viability (poly(vinyl pyrrolidone) reduces cytotoxicity) and high transfection efficiency. Sagara et al. 42 also synthesized galactose-PEG-PEI (gal-PEG-PEI) conjugates to inhibit nonspecific ionic interaction between polyplexes and target cells. They were able to transfect hepatocytes with the same efficiency as the nonmodified PEI, however, they observed that when more than 1% of amino nitrogens of the polymer were galactosylated, the DNA condensation was reduced since increased galactosylation decreases the packing capacity. In comparison with previous studies, GC-g-PEI copolymer showed reduced cytotoxicity by biocompatible chitosan and low molecular weight PEI (Figure 4) , and significantly enhanced transfection efficiency by the application of ASGPR for hepatocyte targeting and high-buffering capacity of PEI in vitro ( Figure 5 ).
In vivo distribution of 99m Tc-labeled complexes
Implantable infusion pumps have been developed for a number of diseases, and there has been remarkable complexes at functional N/P ratios in HepG2 cells; (c) luciferase activity of GC-g-PEI/DNA complexes at a charge ratio of 14 normalized by that of chitosan-graft-PEI (CHI-g-PEI)/DNA complexes on HepG2 and HeLa cells; (d) competition assay of GC-g-PEI/DNA complexes prepared at a charge ratio of 14 by adding free galactose (100 mM) as a competitor of the galactose in GC-g-PEI and (e) effect of bafilomycin A1 on gene transfection.
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H-L Jiang et al progress in endoscopic and laparoscopic surgical techniques. This progress in surgical techniques and devices could make i.p. administration a conventional and feasible approach for future clinical applications. 43 Also, it has been speculated that materials such as fusion proteins injected into the peritoneum reach all tissues via systemic circulation. Tc-CHI-g-PEI/DNA complexes were accumulated in the liver at 60 min than at 15 min, although this accumulation was reduced at 180 min after i.p. injection, whereas more 99m Tc-GC-g-PEI/DNA complexes had accumulated after 180 min, suggesting that the accumulation of 99m Tc-GC-g-PEI/DNA complexes in the liver was mediated by ASGPR. This result indicates that the GC-g-PEI is more efficient in reaching the liver after i.p. administration.
In vivo transfection
To confirm whether GC-g-PEI is a more efficient gene carrier for targeting hepatocytes in vivo compared to PEI 25K, green fluorescent protein (GFP) expression in the liver was observed after i.p. administration of PEI/DNA and GC-g-PEI/DNA complexes ( Figure 7) . As expected from the in vitro study and in vivo imaging results, GC-g-PEI/ DNA complexes showed excellent gene expression in vivo, indicating that this copolymer is a much more efficient gene carrier for hepatocyte targeting than PEI 25K.
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Conclusions
We have successfully prepared and evaluated a novel GC-g-PEI copolymer as a new gene carrier. GC-g-PEI showed a great ability to form complexes with DNA and had suitable physicochemical properties for a gene delivery system. This copolymer had low cytotoxicity and exhibited enhanced gene transfer efficiency and specificity in vitro as well as in vivo when compared to PEI 25K. Therefore, GCg-PEI has the potential to be a safe and efficient gene carrier. We are currently focusing on more comprehensive studies to characterize GC-g-PEI, especially in liver cancer therapy via i.p. administration.
Materials and methods
Materials
Chitosan (molecular weight, 100 kDa; deacetylation degree, 87%) was kindly supplied by Jakwang (Ansung, 
Preparation of GC and GC-g-PEI
The GC was synthesized according to a method previously reported. 14 GC-g-PEI copolymer was synthesized according to a method previously reported. 26 
Characterization of copolymer
The composition of the prepared GC-g-PEI copolymer was estimated by measuring 1 H NMR (Avance 600, Bruker, Germany). The molecular weight of the GC-g-PEI copolymer was measured using a gel permeation chromatography column with multi-angle laser scattering at a laser (Dawn Eos, Wyatt, CA, USA) wavelength of 690 nm.
Preparation of GC-g-PEI/DNA complexes
Complexes were prepared by adding copolymer solution to equal volumes of calf thymus DNA (for size and x potential measurements), pGL3-control solution (for luciferase assay) or pEGFP-N2 (for GFP expression), vortexing gently and incubating at room temperature for 30 min.
Gel retardation assay
The DNA condensation ability of the copolymer was confirmed by electrophoresis. DNA retardation was observed by irradiation with UV light and assayed with Cam2com software.
Observation with energy-filtering transmission electron microscopy (EF-TEM)
The morphology of the GC-g-PEI/DNA (pGL3) complexes was observed using EF-TEM (LIBRA 120, Carl Zeiss, Germany). 26 
Measurement of particle size and x potential
The size and surface charge of the GC-g-PEI/DNA complexes were measured at 251C using an electrophoretic light scattering spectrophotometer (ELS 8000, Otsuka Electronics, Osaka, Japan) and 90 and 201 scattering angles.
DNA protection and release assay
Protection and release of DNA in complexes were measured using electrophoresis, according to the modified method of Park et al.
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Cell viability assays and transfection efficiency studies in vitro
In vitro cytotoxicity tests and transfection efficiency studies were evaluated according to a method previously reported. 26 
Radiolabeling with 99m
Tc and imaging studies in vivo
Tc and imaging studies were performed according to a method previously reported. 46 In vivo imaging studies were performed in accordance with guidelines set by the Chonbuk National University Medical School Committee. Anesthesia was maintained during the imaging procedure. Five-week-old female BALB/c mice were injected with free Tc-GC-g-PEI/DNA complexes (1 mCi/mouse) by i.p. administration (n ¼ 3). Static images were obtained 15, 60 and 180 min after i.p. injection using a gamma camera (Vertex, ADAC, Milpitas, CA, USA).
Transfection efficiency in vivo
Six-week-old female BALB/c mice (Breeding and Research Center, Seoul National University, Korea) were used throughout this study, following the policy and regulations for the care and use of laboratory animals (Laboratory Animal Center, Seoul National University, Korea). The in vivo transfection efficiency of GC-g-PEI was determined by i.p. administration using 50 mg of 
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H-L Jiang et al pEGFP-N2 pDNA in a 200 ml injection volume (n ¼ 3). Animals were killed 48 h after i.p. injection, and livers were isolated and perfused in ice-cold 4% phosphatebuffered formaldehyde. Tissue was fixed at room temperature and embedded in Tissue-Tek OCT (Sakura, Torrance, CA, USA). Tissue cryosections (10 mm) were cut with a microtome (Leica, Nussloch, Germany) and mounted on slides for analysis.
